Multiple Myeloma Treatment Options First Line Therapy Multiple myeloma treatment options | first line therapy. Bortezomib, lenalidomide, and dexamethasone (vrd) is a preferred first line treatment option for patients with newly diagnosed multiple myeloma. whether the addition of the anti cd38 monoclonal ant.
First Line Treatment Of Non Transplant Eligible Multiple Myeloma Multiple myeloma (mm) is a plasma cell neoplasm characterized by clonal plasma cells that produce a monoclonal immunoglobulin. these plasma cells proliferate in the bone marrow and can result in extensive skeletal destruction with osteolytic lesions, osteopenia, and or pathologic fractures. additional disease related complications include. First line treatment algorithm for transplant and not transplant eligible multiple myeloma patients. among the key questions which remain to be answered regarding induction therapy is whether the minimal residual disease (mrd) driven tailored treatment prolongation, including asct, can find its place in daily practice. When you are first diagnosed with multiple myeloma, the goal of treatment is to provide symptom relief and reduce the amount of myeloma cells in your body as quickly and safely as possible. the standard of care for newly diagnosed multiple myeloma is called induction therapy , followed by an autologous stem cell transplant (if eligible) and maintenance therapy ; collectively, these are. Treatment options for multiple myeloma and other plasma.
Comments are closed.